An algorithmic approach to the diagnosis of pancreatic neoplasms

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 3, 2009, Pages 454-464

  Klimstra, David S ^a   Pitman, Martha B ^b   Hruban, Ralph H ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PANCREAS TUMOR; REVIEW; TUMOR CLASSIFICATION;

ALGORITHMS; CELL DIFFERENTIATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PANCREATIC NEOPLASMS;

EID: 62249206562     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. Washington, DC: American Registry of Pathology; 2007. Atlas of Tumor Pathology; 4th series, fascicle 6.
2. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156.
3. Klimstra DS. Cell lineage in pancreatic neoplasms. In: Sarkar FH, Dugan MC, eds. Pancreatic Cancer: Advances in Molecular Pathology, Diagnosis and Clinical Management. Natick, MA: Bio Techniques Books; 1998:21-47.
4. Monges GM, Mathoulin-Portier MP, Acres RB, et al. Differential MUC 1 expression in normal and neoplastic human pancreatic tissue: an immunohistochemical study of 60 samples. Am J Clin Pathol.1999;112:635- 640.
5. Lee MJ, Lee HS, Kim WH, et al. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol. 2003;16:403-410.
6. Ali A, Serra S, Asa SL, et al. The predictive value of CK19 and CD99 in pancreatic endocrine tumors. Am JSurgPathol.2006;30:1588-1594.
7. Lloyd RV, Mervak T, Schmidt K, et al. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms. Am J Surg Pathol. 1984;8:607-614.
8. Klimstra DS, Heffess CS, Oertel JE, et al. Acinar cell carcinoma of the pancreas: a clinicopathologic study of 28 cases. Am J Surg Pathol.1992;16:815-837.
9. Klimstra DS, Rosai J, Heffess CS. Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol.1994;18:765-778.
10. Albores-Saavedra J, Angeles-Angeles A, Nadji M, et al. Mucinous cystad enocarcinoma of the pancreas: morphologic and immunocytochemical observations. Am JSurgPathol.1987;11:11-20.
11. Adsay NV, Longnecker DS, Klimstra DS. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol. 2000;17:16-30.
12. Kosmahl M, Wagner J, Peters K, et al. Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol. 2004;28:339-346.
13. Kosmahl M, Pauser U, Anlauf M, et al. Pancreatic ductal adenocarcinomas with cystic features: neither rare nor uniform. Mod Pathol. 2005;18:1157-1164.
14. Ligneau B, Lombard-Bohas C, Partensky C, et al. Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases. Am J Surg Pathol. 2001;25:752-760.
15. Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794-799.
16. Shorter NA, Glick RD, Klimstra DS, et al. Malignant pancreatic tumors in childhood and adolescence: the Memorial Sloan-Kettering experience, 1967 to present. J Pediatr Surg. 2002;37:887-892.
17. Howard JM, Hess W. History of the Pancreas: Mysteries of a Hidden Organ. New York, NY: Kluwer Academic/Plenum Publishers; 2002.
18. Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol. 2001;25:26-42.
19. Klimstra DS, Wenig BM, Adair CF, et al. Pancreatoblastoma: a clinicopathologic study and review of the literature. Am J Surg Pathol. 1995;19:1371-1389.
20. Hoorens A, Lemoine NR, McLellan E, et al. Pancreatic acinar cell carcinoma: an analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol. 1993;143:685-698.
21. Abraham SC, Klimstra DS, Wilentz RE, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002;160:1361-1369.
22. Klimstra DS, Wenig BM, Heffess CS. Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential. Semin Diagn Pathol. 2000;17:66-80.
23. Notohara K, Hamazaki S, Tsukayama C, et al. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Am J Surg Pathol. 2000;24:1361-1371.
24. Klöppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas: the features are becoming clearer. Pancreatology. 2001;1:648-655.
25. Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999;23:410-422.
26. Thompson LD, Becker RC, Przygodzki RM, et al. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. Am J Surg Pathol. 1999;23:1-16.
27. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-987.
28. Longnecker DS, Adler G, Hruban RH, Klöppel G. Intraductal papillarymucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000:237-240. World Health Organization Classification of Tumours.
29. Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372-1377.
30. Hamilton SR, Aaltonen LA. Pathology and Genetics of Tumors of the Digestive System. Lyon, France: IARC Press; 2000. World Health Organization Classification of Tumours.
31. Molberg KH, Heffess C, Delgado R, et al. Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region. Cancer. 1998;82:1279-1287.
32. Adsay NV, Hasteh F, Cheng JD, et al. Lymphoepithelial cysts of the pancreas: a report of 12 cases and a review of the literature. Mod Pathol. 2002;15:492-501.
33. Goggins M, Offerhaus GJ, Hilgers W, et al. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology: poor differentiation, a syncytial growth pattern, and pushing borders suggest RER +. Am J Pathol. 1998;152:1501-1507.
34. Tajiri T, Tate G, Kunimura T, et al. Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary- mucinouscarcinoma, and ductal adenocarcinoma of the pancreas. Pancreas. 2004;29:116-122.
35. Cantrell BB, Cubilla AL, Erlandson RA, et al. Acinar cell cystadenocarcinoma of human pancreas. Cancer. 1981;47:410-416.
36. Basturk O, Zamboni G, Klimstra DS, et al. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms. Am J Surg Pathol. 2007;31:363-370.
37. Perez-Ordonez B, Naseem A, Lieberman PH, et al. Solid serous adenoma of the pancreas: the solid variant of serous cystadenoma? Am J Surg Pathol. 1996;20:1401-1405.
38. Ballas KD, Rafailidis SF, Demertzidis C, et al. Mixed exocrine-endocrine tumor of the pancreas. JOP. 2005;6:449-454.
39. Klimstra D, Perren A, Oberg K, et al. Pancreatic endocrine tumours: non-functioning tumours and microadenomas. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: I ARC Press; 2004:201-204. World Health Organization Classification of Tumours.
40. Ohike N, Kosmahl M, Klöppel G. Mixed acinar-endocrine carcinoma of the pancreas: a clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch. 2004;445:231-235.
41. Adsay NV, Andea A, Basturk O, et al. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch. 2004;444:527-535.
42. Albores-Saavedra J, Heffess C, Hruban RH, et al. Recommendations for the reporting of pancreatic specimens containing malignant tumors: the Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol. 1999;111:304-307.
43. Demetter P, Cuvelier CA. Guidelines for adequate histopathological reporting of pancreatic ductal adenocarcinoma resection specimens. Acta Gastroenterol Belg. 2004;67:46-49.
44. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
45. Klöppel G, Lingenthal G, von Bulow M, et al. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology. 1985;9:841-856.
46. Adsay NV, Basturk O, Bonnett M, et al. A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma. Am J Surg Pathol. 2005;29:724-733.
47. Heitz PU, Komminoth P, Perren A, et al. Pancreatic endocrine tumours: introduction. In: Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: I ARC Press; 2004:177-182. World Health Organization Classification of Tumours.
48. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-gradeand intermediate-grade groups. J Clin Oncol. 2002;20:2633-2642.